Eddie Davis, DPM
Foot & Ankle Surgery · San Antonio, TXNPI 1609075902
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (48.2%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 37 manufacturers reported payments, led by Endo Pharmaceuticals Inc. at 41.4% of the total.
Across 206 payments — averaging $101.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Endo Pharmaceuticals Inc.$9K
- Stryker$5K
- Endo USA, Inc.$3K
- Medinc Of Texas$1K
- Smith+Nephew$470
- Paratek Pharmaceuticals, Inc.$351
- plus $2K from 31 others
What the payments were for
- Consulting fees$10,11048%
- Travel & lodging$2,67613%
- Food & beverage$6,97633%
- Education$1,2016%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Endo Pharmaceuticals Inc. | 8 | $8,677 |
| Stryker | 82 | $5,031 |
| Endo USA, Inc. | 4 | $2,920 |
| Medinc Of Texas | 3 | $1,260 |
| Smith+Nephew | 15 | $470 |
| Paratek Pharmaceuticals, Inc. | 8 | $351 |
| Amgen(2 entities) | 11 | $325 |
| Treace Medical Concepts, Inc. | 9 | $185 |
| Averitas Pharma Inc. | 4 | $181 |
| Orthofix Medical, Inc. | 14 | $158 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 4 | $145 |
| Johnson & Johnson | 2 | $134 |
| Organogenesis Inc. | 1 | $125 |
| AbbVie | 5 | $115 |
| Merck | 3 | $113 |
| Pacira Pharmaceuticals Incorporated | 2 | $111 |
| Kerecis Limited | 5 | $66 |
| Next Science LLC | 3 | $59 |
| Vertex | 2 | $59 |
| Nevro Corp. | 2 | $52 |
| Mimedx Group, Inc. | 1 | $48 |
| Mission Medical Distribution, LLC | 2 | $42 |
| Ossio Inc | 1 | $41 |
| Convatec Inc. | 1 | $39 |
| Integra Lifesciences Corporation | 1 | $35 |
| Abbott | 2 | $35 |
| IBSA Pharma Inc. | 1 | $21 |
| Novastep Inc. | 1 | $19 |
| Stimwave Technologies Incorporated | 1 | $19 |
| Solventum Corporation | 1 | $18 |
| Lifenet Health | 1 | $18 |
| Melinta Therapeutics, LLC | 1 | $18 |
| Sebela Pharmaceuticals Inc. | 1 | $17 |
| ANI Pharmaceuticals, Inc. | 1 | $16 |
| Medtronic | 1 | $14 |
| Bioventus LLC | 1 | $14 |
| Reprise Biomedical, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$20,963 in reported general payments places this provider in the 85th percentile of 684 foot & ankle surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 31 | $690 |
| Cephalexin | 33 | $257 |
| Allopurinol | 17 | $131 |
| Mupirocin | 21 | $113 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 14 | $62 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in San Antonio
- Ian BarronSan Antonio$162K
- Walter StrashSan Antonio$86K
- Thomas ZgonisSan Antonio$79K
- Collin PehdeSan Antonio$49K
- William McGarveyKaty$3.5M
- Eugene CurryDallas$3.1M
- Graham HamiltonEdinburg$2.1M
- Mark DaltonAustin$1.9M
- Kevin VarnerHouston$1.1M
- Paul KimDallas$928K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.